Inspire is the first and only FDA-approved implantable device for moderate-to-severe obstructive sleep apnea — an alternative for patients who cannot tolerate CPAP. It is completely mask-free.
Inspire therapy takes a fundamentally different approach to treating sleep apnea. Instead of using air pressure and a mask, a small device is implanted beneath the skin during a same-day, outpatient procedure.
While you sleep, the device gently stimulates the hypoglossal nerve, which controls the muscles of the tongue and airway. With each breath, it moves these muscles slightly forward, keeping your airway open so air can flow freely.
You stay in complete control: simply press a button on a small handheld remote to turn the therapy on before bed and off when you wake. There is no mask, no hose, and no machine on the nightstand.
A simple, intuitive system that works quietly with your natural breathing.
A small device is implanted during a same-day outpatient procedure, with most patients returning home the same day and resuming normal activity soon after.
Before bed, you simply press a button on a small handheld remote to turn the therapy on — no mask, hoses, or setup required.
As you sleep, the device continuously senses your natural breathing rhythm and times its therapy precisely to each breath.
Gentle pulses stimulate the hypoglossal nerve, moving the tongue and airway muscles forward to keep the airway open all night long.
Inspire is right for select patients. Our specialists confirm candidacy through a careful evaluation.
Inspire therapy is approved for adult patients aged 18 years and older.
It is indicated for those diagnosed with moderate-to-severe obstructive sleep apnea.
It is designed for patients who have been unable to use or consistently tolerate CPAP therapy.
Candidates generally have a BMI of 32–35 or below, with appropriate airway anatomy confirmed by Drug-Induced Sleep Endoscopy (DISE).
Find out if Inspire therapy is right for you. Request a consultation to begin your evaluation with our sleep specialists.